Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1949 1
1951 1
1953 1
1956 1
1958 1
1959 1
1961 1
1964 2
1965 5
1966 26
1967 57
1968 96
1969 79
1970 102
1971 80
1972 91
1973 108
1974 132
1975 76
1976 75
1977 91
1978 78
1979 87
1980 85
1981 83
1982 94
1983 63
1984 94
1985 98
1986 119
1987 118
1988 126
1989 159
1990 205
1991 234
1992 217
1993 279
1994 262
1995 231
1996 231
1997 192
1998 170
1999 155
2000 156
2001 147
2002 153
2003 140
2004 153
2005 157
2006 157
2007 146
2008 182
2009 175
2010 196
2011 197
2012 200
2013 197
2014 221
2015 195
2016 193
2017 187
2018 209
2019 116
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

7,539 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L; CARES Investigators. White WB, et al. N Engl J Med. 2018 Mar 29;378(13):1200-1210. doi: 10.1056/NEJMoa1710895. Epub 2018 Mar 12. N Engl J Med. 2018. PMID: 29527974 Free article. Clinical Trial.
Allopurinol: insights from studies of dose-response relationships.
Day RO, Kannangara DR, Stocker SL, Carland JE, Williams KM, Graham GG. Day RO, et al. Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):449-462. doi: 10.1080/17425255.2017.1269745. Epub 2016 Dec 20. Expert Opin Drug Metab Toxicol. 2017. PMID: 27927043 Review.
How to prevent allopurinol hypersensitivity reactions?
Stamp LK, Barclay ML. Stamp LK, et al. Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i35-i41. doi: 10.1093/rheumatology/kex422. Rheumatology (Oxford). 2018. PMID: 29272508 Review.
Allopurinol: Old Drug, New Indication in Neonates?
Annink KV, Franz AR, Derks JB, Rudiger M, Bel FV, Benders MJNL. Annink KV, et al. Curr Pharm Des. 2017;23(38):5935-5942. doi: 10.2174/1381612823666170918123307. Curr Pharm Des. 2017. PMID: 28925896 Review.
New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert.
Choi H, Neogi T, Stamp L, Dalbeth N, Terkeltaub R. Choi H, et al. Arthritis Rheumatol. 2018 Nov;70(11):1702-1709. doi: 10.1002/art.40583. Arthritis Rheumatol. 2018. PMID: 29869840 Free PMC article.
Allopurinol as a therapeutic option in cardiovascular disease.
Okafor ON, Farrington K, Gorog DA. Okafor ON, et al. Pharmacol Ther. 2017 Apr;172:139-150. doi: 10.1016/j.pharmthera.2016.12.004. Epub 2016 Dec 2. Pharmacol Ther. 2017. PMID: 27916655 Review.
Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
Chou HW, Chiu HT, Tsai CW, Ting IW, Yeh HC, Huang HC, Kuo CC; CMUH Kidney Research Group. Chou HW, et al. Nephrol Dial Transplant. 2018 Sep 1;33(9):1620-1627. doi: 10.1093/ndt/gfx313. Nephrol Dial Transplant. 2018. PMID: 29165620
7,539 results
Jump to page
Feedback